| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |